番茄社区

Endocrinology >

Type 2 Diabetes

News, opinions and meeting coverage in endocrinology.

New Treatments for High Potassium on the Horizon

But ultimate success is far from guaranteed.

Stent Graft Keeps Vascular Access Clear

Should change practice, study leader says.

Insulin and Insulina: Bridging the Gap

Physicians need to be aware of patients' beliefs about medicinal plants.

Aphrodisiac Aids Genetic Type 2 Diabetes

About 4% of diabetes patients may benefit from yohimbine.

Review: Telcare Glucose Meter

An easy-to-use glucose monitor uploads data to the cloud for ready access.

Metformin and TSH: Is There a Link?

Canadian study suggests raises questions about metformin use in diabetics with underlying hypothyroidism.

HypoMap: A New Way to Track Hypoglycemia

Keeping accurate tabs on hypoglycemic events is a challenge, since they often happen between clinic visits. But Joslin Diabetes Center and technology company Glooko are trying to change that.

Glucometer Control Test Underused in Diabetes

ORLANDO -- Control solution for ensuring the proper function of glucose meters didn't appear to be a priority among physicians, pharmacists, or patients, researchers reported here.

Patients Want Diabetes-Friendly Meals on the Menu

ORLANDO -- It's easy to find heart-healthy or vegetarian-friendly meals labeled on restaurant menus, but diabetes patients are often left in the dark about options best suited to them.

FDA: No Clear Sign of Harm With Olmesartan in Diabetics

The evidence linking use of the angiotensin II receptor blocker (ARB) olmesartan in patients with diabetes and increased cardiovascular risk is not conclusive, according to a completed FDA safety review.

Obesity, T2D May Alter Gut Bacteria

CHICAGO -- The portfolio of gut bacteria in patients with obesity and type 2 diabetes may look different from that of healthy people, researchers reported here.

Victoza Accused of Causing Pancreatitis

The watchdog group Public Citizen has conducted its own analysis of FDA adverse event reports and concluded that the type 2 diabetes drug liraglutide(Victoza) likely causes pancreatitis, the group said.

Small eGFR Drops May Predict Kidney Outcomes

Declines in estimated glomerular filtration rate (eGFR) smaller than those that currently attract clinical attention may help predict the risk of end-stage renal disease, researchers reported.

The Day My Brother Became a Statistic

My brother would have turned 37 today. Instead, he became a statistic in 1995.

Bed Rest in Pregnancy Raises Diabetes Risk

CHICAGO -- Women who are prescribed long-term bed rest for troubled pregnancies are at increased risk of developing gestational diabetes, researchers said here.

Hypoglycemia at Night Tied to Arrhythmias

Nocturnal hypoglycemia was a major risk factor for cardiac arrhythmias in type 2 diabetes patients who were already at an increased risk for cardiovascular events, according to British researchers.

Forget Glucometers, Use Voodoo Dolls Instead: That's Improbable!

A weekly report from our friends at Improbable Research.

Fatty Liver Tied to Diabetes, Atherosclerosis

LONDON -- Non-alcoholic fatty liver disease (NAFLD) is an independent predictor of both type 2 diabetes and carotid atherosclerosis, according to two studies presented here at the annual meeting of the European Association for the Study of the Liver.

ACC: Metformin No Help in MI Recovery

WASHINGTON -- Metformin started soon after reperfusion in the acute setting didn't help cardiac function recover in nondiabetic heart attack patients, a trial showed.

Abbott Continues Glucose Meter Recall

Abbott Diabetes Care is continuing its recall of FreeStyle and FreeStyle Flash blood glucose meters because of the potential for erroneous low blood sugar readings, the company said.

New Guideline Lowers eGFR for Dialysis Start

New Canadian guidelines suggest that nephrologists can wait to start dialysis in some chronic kidney disease patients until their estimated glomerular filtration rate drops below the 10 to 12 mL/min now commonly used.

Tandem Expands Leaky Insulin Cartridge Recall

Tandem Diabetes has expanded a recall of insulin cartridges for its t:slim Insulin Pump that run the risk of leaking, the company said in a statement.

11 Endocrinology Apps for Docs' Toolboxes

Even if endocrinologists aren't already suggesting smartphone apps to their patients, they've likely been asked to offer up recommendations. Here's a list of 11 apps you should know about.

FDA Rules Differ for OTC vs. POC Glucose Monitors

The FDA has released two draft guidances that establish a line between over-the-counter and point-of-care blood glucose monitors.

Diabetes: TAVI Trumps Heart Surgery

Patients with diabetes who had aortic stenosis fared better in terms of mortality and kidney function during the first year if they underwent transcatheter aortic valve implantation (TAVI) rather than surgery, a post-hoc analysis found.

Surgery Beats Medical Tx for Diabetes 'Cure'

ATLANTA -- Bariatric surgery's beneficial effects for type 2 diabetes were significantly greater than even the most rigorous medical and lifestyle interventions, a researcher said here.

Combo Angiotensin Tx Ups Kidney Risks

ATLANTA -- In yet another trial, dual blockade of the renin-angiotensin system (RAAS) didn't slow progression of kidney disease in diabetic patients and carried a higher risk of serious adverse events compared with monotherapy, researchers reported here.

Daytime Snoozing May Tell Risk of Hypoglycemia

Older patients with diabetes who are overly tired during the day may be at a higher risk for hypoglycemia, researchers reported.

In Some Patients Metformin Impairs Thinking

The widely acclaimed diabetes drug metformin was linked with impaired brain function in patients who took the drug, although supplementation with vitamin B12 may alleviate metformin-induced deficiencies, according to new research.

Medicare's DME Bidding Program Criticized

Despite complaints from multiple parties, Medicare's bidding program for durable medical equipment -- including diabetes supplies -- now includes suppliers to half of all program beneficiaries.

FDA Goes After Fake Diabetes Therapies

The FDA has sent letters to 15 companies warning them to stop marketing products that falsely claim to treat diabetes, the agency announced.

Society Seconds Call for Incretin Data

SAN FRANCISCO -- The Endocrine Society has joined its voice to the recent call for incretin drugmakers to release all patient-level data on their products, the group announced at its annual meeting.

Diabetes Experts Divided About 'Lone Wolf' Butler

Top experts in diabetes and endocrinology have offered mixed reactions to a profile of Peter Butler, MD, chair of endocrinology at the University of California Los Angeles, in the New York Times.

High-Salt Diet May Boost Cortisol

Eating a diet high in sodium increased levels of cortisol and other metabolites, potentially giving rise to metabolic syndrome, researchers found.

Finger Stick Has Promise as Prediabetes Test

PHOENIX -- Measuring capillary blood via finger stick assay was as accurate as venous blood sample assays in predicting 5-year likelihood of diabetes, researchers reported here.

How Much Exercise to Burn Off a Burger?

Menus displaying the amount of exercise required to burn off calories in a meal had some impact on food choice, researchers found.

C. Diff Dangerous in ESRD

ORLANDO -- Kidney dialysis patients who are infected with Clostridium difficile have a greater risk of infection relapse and also have a higher all-cause mortality that patients who do not have kidney disease, researchers said here.

Cardio Notes: Sex Improves with Stenting

Opening the arteries of those with stable coronary disease also opens the door to an improved sex life. Also this week, bariatric surgery helps remodel the heart.

No Weight Gain with Linagliptin in Diabetes

The DPP-4 inhibitor linagliptin may control type 2 diabetes with less hypoglycemia or weight gain than glimepiride when used as second-line treatment with metformin, a trial showed.

Tattoos Replace Bracelets for Medical Alerts

PHILADELPHIA -- As more people with diabetes replace their medical alert bracelets with tattooed warnings, there might be a need for a standard design and body location, a researcher here said.

鈥�

19